Communiqués SpringWorks Therapeutics, Inc.

Actions

SWTX

US85205L1070

Marché Fermé - Nasdaq Autres places de cotation 22:00:03 31/05/2024			Varia. 5j.	Varia. 1 janv.
41,44 ^USD	-2,73 %		-2,21 %	+13,55 %

23/05	SpringWorks Therapeutics, Inc. annonce que des données seront présentées lors de la réunion annuelle de la Société américaine d'oncologie clinique en 2024	CI
15/05	Transcript : SpringWorks Therapeutics, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 03:40 PM

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

SpringWorks Therapeutics Announces Data to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	23/05	GL
SpringWorks Therapeutics to Participate in the BofA Securities 2024 Health Care Conference	08/05	GL
SpringWorks Therapeutics: Q1 Earnings Snapshot	02/05	AQ
SpringWorks Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Business Updates	02/05	GL
SpringWorks Therapeutics Announces Abstracts Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	24/04	GL
SpringWorks Therapeutics to Report First Quarter 2024 Financial Results Thursday, May 2, 2024	18/04	GL
SpringWorks Therapeutics Initiates Rolling Submission of New Drug Application to the FDA for Mirdametinib for the Treatment of Children and Adults with NF1-PN	04/03	GL
SpringWorks Therapeutics Announces European Medicines Agency Validation for Marketing Authorization Application of Nirogacestat for the Treatment of Adults with Desmoid Tumors	29/02	GL
SpringWorks Therapeutics Announces European Medicines Agency Validation for Marketing Authorization Application of Nirogacestat for the Treatment of Adults with Desmoid Tumors	29/02	AQ
SpringWorks Therapeutics: Q4 Earnings Snapshot	27/02	AQ
SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Updates	27/02	GL
SpringWorks Therapeutics to Present at Upcoming Investor Conferences	22/02	GL
SpringWorks Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference	31/01	GL
SpringWorks Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference	31/01	AQ
SpringWorks Therapeutics Highlights 2023 Accomplishments and Anticipated Milestones for 2024 at the 42nd Annual J.P. Morgan Healthcare Conference	08/01	GL
SpringWorks Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference	21/12	GL
SpringWorks Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares	08/12	GL
SpringWorks Therapeutics Announces Pricing of Upsized Public Offering of Common Stock	05/12	GL
SpringWorks Therapeutics Announces Proposed Public Offering of Common Stock	04/12	GL
SpringWorks Therapeutics to Participate in the 6th Annual Evercore ISI HealthCONx Conference	29/11	GL

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués SpringWorks Therapeutics, Inc.

Actions

SWTX

US85205L1070

Communiqués

Filtres